{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:39:07Z","timestamp":1711096747671},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ADHD Atten Def Hyp Disord"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12402-015-0166-1","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T06:57:44Z","timestamp":1421737064000},"page":"179-181","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Possible atomoxetine-induced vitiligo: a case report"],"prefix":"10.1007","volume":"7","author":[{"given":"\u00d6zlem","family":"Bilgi\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Bilgi\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"166_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH et al (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology 27:699\u2013711","journal-title":"Neuropsychopharmacology"},{"key":"166_CR2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0738-081X(97)00125-9","volume":"15","author":"J Castanet","year":"1997","unstructured":"Castanet J, Ortonne JP (1997) Pathophysiology of vitiligo. Clin Dermatol 15:845\u2013885","journal-title":"Clin Dermatol"},{"key":"166_CR3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2133.2006.07293.x","volume":"154","author":"CY Chu","year":"2006","unstructured":"Chu CY, Liu YL, Chiu HC, Jee SH (2006) Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species. Br J Dermatol 154:1071\u20131079","journal-title":"Br J Dermatol"},{"key":"166_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1600-0749.2003.00015.x","volume":"16","author":"MR Cucchi","year":"2003","unstructured":"Cucchi MR, Frattini P, Santagostina G, Preda S, Orecchia G (2003) Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase. Pigment Cell Res 16:111\u2013116","journal-title":"Pigment Cell Res"},{"key":"166_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroimage.2013.08.001","volume":"86","author":"YS Ding","year":"2014","unstructured":"Ding YS, Naganawa M, Gallezot JD, Nabulsi N, Lin SF, Ropchan J et al (2014) Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: implications on treatment of depression and ADHD. Neuroimage 86:164\u2013171","journal-title":"Neuroimage"},{"key":"166_CR6","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.jaad.2011.03.030","volume":"66","author":"P Ghasri","year":"2012","unstructured":"Ghasri P, Gattu S, Saedi N, Ganesan AK (2012) Chemical leukoderma after the application of a transdermal methylphenidate patch. J Am Acad Dermatol 66:e237\u2013e238","journal-title":"J Am Acad Dermatol"},{"key":"166_CR7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/jpet.114.217380","volume":"351","author":"SR Jesinkey","year":"2014","unstructured":"Jesinkey SR, Korrapati MC, Rasbach KA, Beeson CC, Schnellmann RG (2014) Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice. J Pharmacol Exp Ther 351:663\u2013673","journal-title":"J Pharmacol Exp Ther"},{"key":"166_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-0960.2009.00583.x","volume":"51","author":"DY Kwon","year":"2010","unstructured":"Kwon DY, Park MH, Oh K, Ryu HJ, Park KW (2010) Acute unilateral poliosis concurrent with trigeminal autonomic cephalalgia: a possible aetiological association. Australas J Dermatol 51:66\u201368","journal-title":"Australas J Dermatol"},{"key":"166_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/nedt.2006.2.4.455","volume":"2","author":"M Ledbetter","year":"2006","unstructured":"Ledbetter M (2006) Atomoxetine: a novel treatment for child and adult ADHD. Neuropsychiatr Dis Treat 2:455\u2013466","journal-title":"Neuropsychiatr Dis Treat"},{"key":"166_CR10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-4632.2011.04914.x","volume":"50","author":"DY Lee","year":"2011","unstructured":"Lee DY, Kim CR, Park JH, Lee JH (2011) The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol 50:925\u2013927","journal-title":"Int J Dermatol"},{"key":"166_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2013.08.009","volume":"41","author":"MR Mirbolooki","year":"2014","unstructured":"Mirbolooki MR, Upadhyay SK, Constantinescu CC, Pan ML, Mukherjee J (2014) Adrenergic pathway activation enhances brown adipose tissue metabolism: a [18F]FDG PET\/CT study in mice. Nucl Med Biol 41:10\u201316","journal-title":"Nucl Med Biol"},{"key":"166_CR12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.survophthal.2011.02.003","volume":"56","author":"BS Modjtahedi","year":"2011","unstructured":"Modjtahedi BS, Alikhan A, Maibach HI, Schwab IR (2011) Diseases of periocular hair. Surv Ophthalmol 56:416\u2013432","journal-title":"Surv Ophthalmol"},{"key":"166_CR13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0749.2007.00408.x","volume":"20","author":"MR Namazi","year":"2007","unstructured":"Namazi MR (2007) Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? Pigment Cell Res 20:360\u2013363","journal-title":"Pigment Cell Res"},{"key":"166_CR14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2007.08406.x","volume":"158","author":"MR Namazi","year":"2008","unstructured":"Namazi MR (2008) Proton pump inhibitors may trigger vitiligo by rendering melanocytes prone to apoptosis. Br J Dermatol 158:844\u2013845","journal-title":"Br J Dermatol"},{"key":"166_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0378-6323.90944","volume":"78","author":"A Palit","year":"2012","unstructured":"Palit A, Inamadar AC (2012) Childhood vitiligo. J Dermatol Venereol Leprol 78:30\u201341","journal-title":"J Dermatol Venereol Leprol"},{"key":"166_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaapos.2005.02.016","volume":"9","author":"A Roberts","year":"2005","unstructured":"Roberts A, Kaye LC, Memon A, Parslew R, Kaye SB (2005) Unilateral poliosis of the eyelashes in children associated with vitiligo. J AAPOS 9:295\u2013296","journal-title":"J AAPOS"},{"key":"166_CR17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1345\/aph.19090","volume":"33","author":"M Sabat\u00e9","year":"1999","unstructured":"Sabat\u00e9 M, Bosch A, Pedr\u00f3s C, Figueras A (1999) Vitiligo associated with tolcapone and levodopa in a patient with Parkinson\u2019s disease. Ann Pharmacother 33:1228\u20131229","journal-title":"Ann Pharmacother"},{"key":"166_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2133.1995.tb08660.x","volume":"132","author":"KU Schallreuter","year":"1995","unstructured":"Schallreuter KU (1995) Beta-adrenergic blocking drugs may exacerbate vitiligo. Br J Dermatol 132:168\u2013169","journal-title":"Br J Dermatol"},{"key":"166_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","volume":"38","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N (2011) Vitiligo: a review of the published work. J Dermatol 38:419\u2013431","journal-title":"J Dermatol"}],"container-title":["ADHD Attention Deficit and Hyperactivity Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-015-0166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12402-015-0166-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-015-0166-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T10:51:12Z","timestamp":1559472672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12402-015-0166-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1007\/s12402-015-0166-1","relation":{},"ISSN":["1866-6116","1866-6647"],"issn-type":[{"value":"1866-6116","type":"print"},{"value":"1866-6647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}